Clark William D 4
4 · GENOCEA BIOSCIENCES, INC. · Filed Feb 18, 2021
Insider Transaction Report
Form 4
Clark William D
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2021-02-17$2.72/sh+19,998$54,395→ 63,750 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-02-17−16,500→ 171,000 totalExercise: $1.66Exp: 2030-04-02→ Common Stock (16,500 underlying) - Exercise/Conversion
Common Stock
2021-02-17$1.66/sh+16,500$27,390→ 43,752 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-02-17−19,998→ 86,690 totalExercise: $2.72Exp: 2030-06-01→ Common Stock (19,998 underlying)
Footnotes (2)
- [F1]The option was granted on 6/1/2020 and vests in 48 equal monthly installments beginning on the first monthly anniversary of the grant date.
- [F2]The option was granted on 4/2/2020 and vests in 48 equal monthly installments beginning on the first monthly anniversary of the grant date.